Literature DB >> 12571246

ERK and RhoA differentially regulate pseudopodia growth and retraction during chemotaxis.

Anar A Brahmbhatt1, Richard L Klemke.   

Abstract

Nonmotile cells extend and retract pseudopodia-like structures in a random manner, whereas motile cells establish a single dominant pseudopodium in the direction of movement. This is a critical step necessary for cell migration and occurs prior to cell body translocation, yet little is known about how this process is regulated. Here we show that myosin II light chain (MLC) phosphorylation at its regulatory serine 19 is elevated in growing and retracting pseudopodia. MLC phosphorylation in the extending pseudopodium was associated with strong and persistent amplification of extracellular-regulated signal kinase (ERK) and MLC kinase activity, which specifically localized to the leading pseudopodium. Interestingly, inhibition of ERK or MLC kinase activity prevented MLC phosphorylation and pseudopodia extension but not retraction. In contrast, inhibition of RhoA activity specifically decreased pseudopodia retraction but not extension. Importantly, inhibition of RhoA activity specifically blocked MLC phosphorylation associated with retracting pseudopodia. Inhibition of either ERK or RhoA signals prevents chemotaxis, indicating that both pathways contribute to the establishment of cell polarity and migration. Together, these findings demonstrate that ERK and RhoA are distinct pathways that control pseudopodia extension and retraction, respectively, through differential modulation of MLC phosphorylation and contractile processes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12571246     DOI: 10.1074/jbc.M211873200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  37 in total

1.  Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition.

Authors:  Egle Avizienyte; Valerie J Fincham; Valerie G Brunton; Margaret C Frame
Journal:  Mol Biol Cell       Date:  2004-04-09       Impact factor: 4.138

Review 2.  Beyond desensitization: physiological relevance of arrestin-dependent signaling.

Authors:  Louis M Luttrell; Diane Gesty-Palmer
Journal:  Pharmacol Rev       Date:  2010-04-28       Impact factor: 25.468

3.  R-Ras controls membrane protrusion and cell migration through the spatial regulation of Rac and Rho.

Authors:  Michele A Wozniak; Lina Kwong; David Chodniewicz; Richard L Klemke; Patricia J Keely
Journal:  Mol Biol Cell       Date:  2004-11-03       Impact factor: 4.138

4.  PTP-PEST couples membrane protrusion and tail retraction via VAV2 and p190RhoGAP.

Authors:  Sarita K Sastry; Zenon Rajfur; Betty P Liu; Jean-Francois Cote; Michel L Tremblay; Keith Burridge
Journal:  J Biol Chem       Date:  2006-03-02       Impact factor: 5.157

5.  Profiling signaling polarity in chemotactic cells.

Authors:  Yingchun Wang; Shi-Jian Ding; Wei Wang; Jon M Jacobs; Wei-Jun Qian; Ronald J Moore; Feng Yang; David G Camp; Richard D Smith; Richard L Klemke
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-09       Impact factor: 11.205

6.  Directional persistence of EGF-induced cell migration is associated with stabilization of lamellipodial protrusions.

Authors:  Brian D Harms; Gina M Bassi; Alan Rick Horwitz; Douglas A Lauffenburger
Journal:  Biophys J       Date:  2005-02       Impact factor: 4.033

7.  CD44: target for antiangiogenesis therapy.

Authors:  Horace M DeLisser
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

Review 8.  Integrated morphodynamic signalling of the mammary gland.

Authors:  Nikolce Gjorevski; Celeste M Nelson
Journal:  Nat Rev Mol Cell Biol       Date:  2011-08-10       Impact factor: 94.444

Review 9.  Diversity in arrestin function.

Authors:  Ryan T Kendall; Louis M Luttrell
Journal:  Cell Mol Life Sci       Date:  2009-07-12       Impact factor: 9.261

10.  Loss of SMEK, a novel, conserved protein, suppresses MEK1 null cell polarity, chemotaxis, and gene expression defects.

Authors:  Michelle C Mendoza; Fei Du; Negin Iranfar; Nan Tang; Hui Ma; William F Loomis; Richard A Firtel
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.